MedDataX Logo

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE3

Total Enrollment

1150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-04

Study Completion Date

2029-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT06215716

NASH With Fibrosis MASH With Fibrosis
RECRUITING PHASE3

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04767529

NASH - Nonalcoholic Steatohepatitis
COMPLETED PHASE2

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NCT05039450

NASH - Nonalcoholic Steatohepatitis
ACTIVE_NOT_RECRUITING PHASE2

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT06161571

NASH/MASH NAFLD/MASLD
ACTIVE_NOT_RECRUITING PHASE3

A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NCT03976401

NASH - Nonalcoholic Steatohepatitis
COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

NASH - Nonalcoholic Steatohepatitis MASH - Metabolic Dysfunction-Associated Steatohepatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EFX 50 mg

Group Type EXPERIMENTAL

Efruxifermin

Intervention Type DRUG

Administered by subcutaneous injection

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Administered by subcutaneous injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Efruxifermin

Administered by subcutaneous injection

Intervention Type DRUG

Placebo

Administered by subcutaneous injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cohort 1: Biopsy proven compensated cirrhosis (fibrosis stage 4) due to NASH/MASH
* Cohort 2: Biopsy proven or non-invasively diagnosed compensated cirrhosis (fibrosis stage 4) due to NASH/MASH

Exclusion Criteria

* Other causes of liver disease based on medical history and/or liver histology and/or central laboratory results
* Type 1 diabetes or unstable Type 2 diabetes
* Any current or prior history of decompensated liver disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Akero Therapeutics, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Akero Clinical Study Site

Birmingham, Alabama, United States

Site Status RECRUITING

Akero Clinical Study Site

Dothan, Alabama, United States

Site Status RECRUITING

Akero Clinical Study Site

Chandler, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Flagstaff, Arizona, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Peoria, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Scottsdale, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Tucson, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Tucson, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Tucson, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Tucson, Arizona, United States

Site Status RECRUITING

Akero Clinical Study Site

Conway, Arkansas, United States

Site Status RECRUITING

Akero Clinical Study Site

Jonesboro, Arkansas, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Little Rock, Arkansas, United States

Site Status RECRUITING

Akero Clinical Study Site

North Little Rock, Arkansas, United States

Site Status RECRUITING

Akero Clinical Study Site

Coronado, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Escondido, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Folsom, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Lancaster, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Long Beach, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Los Angeles, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Newport Beach, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Orange, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Pasadena, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Redwood City, California, United States

Site Status RECRUITING

Akero Clinical Study Site

San Francisco, California, United States

Site Status RECRUITING

Akero Clinical Study Site

San Francisco, California, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

San Jose, California, United States

Site Status RECRUITING

Akero Clinical Study Site

Aurora, Colorado, United States

Site Status RECRUITING

Akero Clinical Study Site

Colorado Springs, Colorado, United States

Site Status RECRUITING

Akero Clinical Study Site

Englewood, Colorado, United States

Site Status RECRUITING

Akero Clinical Study Site

New Haven, Connecticut, United States

Site Status RECRUITING

Akero Clinical Study Site

Washington D.C., District of Columbia, United States

Site Status RECRUITING

Akero Clinical Study Site

Bradenton, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Brandon, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Cutler Bay, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Doral, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Fort Myers, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Hialeah Gardens, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Inverness, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Lakewood Rch, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Largo, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Lehigh Acres, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Margate, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Miami, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Miami, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Miami Gardens, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Naples, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

New Port Richey, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Ocala, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Orlando, Florida, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Orlando, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Pembroke Pines, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Riverview, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Sarasota, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Temple Terrace, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Venice, Florida, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Weston, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Zephyrhills, Florida, United States

Site Status RECRUITING

Akero Clinical Study Site

Atlanta, Georgia, United States

Site Status RECRUITING

Akero Clinical Study Site

Gainesville, Georgia, United States

Site Status RECRUITING

Akero Clinical Study Site

Marietta, Georgia, United States

Site Status RECRUITING

Akero Clinical Study Site

Snellville, Georgia, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Chicago, Illinois, United States

Site Status RECRUITING

Akero Clinical Study Site

Hammond, Indiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Indianapolis, Indiana, United States

Site Status RECRUITING

Akero Clinical Study Site

South Bend, Indiana, United States

Site Status RECRUITING

Akero Clinical Study Site

West Des Moines, Iowa, United States

Site Status RECRUITING

Akero Clinical Study Site

Topeka, Kansas, United States

Site Status RECRUITING

Akero Clinical Study Site

Louisville, Kentucky, United States

Site Status RECRUITING

Akero Clinical Study Site

Bastrop, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Covington, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Houma, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Lafayette, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Marrero, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Metairie, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Shreveport, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

West Monroe, Louisiana, United States

Site Status RECRUITING

Akero Clinical Study Site

Baltimore, Maryland, United States

Site Status RECRUITING

Akero Clinical Study Site

Bethesda, Maryland, United States

Site Status RECRUITING

Akero Clinical Study Site

South Dartmouth, Massachusetts, United States

Site Status RECRUITING

Akero Clinical Study Site

Clinton Township, Michigan, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Novi, Michigan, United States

Site Status RECRUITING

Akero Clinical Study Site

Southfield, Michigan, United States

Site Status RECRUITING

Akero Clinical Study Site

Rochester, Minnesota, United States

Site Status RECRUITING

Akero Clinical Study Site

Flowood, Mississippi, United States

Site Status RECRUITING

Akero Clinical Study Site

Columbia, Missouri, United States

Site Status RECRUITING

Akero Clinical Study Site

Kansas City, Missouri, United States

Site Status RECRUITING

Akero Clinical Study Site

St Louis, Missouri, United States

Site Status RECRUITING

Akero Clinical Study Site

St Louis, Missouri, United States

Site Status RECRUITING

Akero Clinical Study Site

Las Vegas, Nevada, United States

Site Status RECRUITING

Akero Clinical Study Site

Jackson, New Jersey, United States

Site Status RECRUITING

Akero Clinical Study Site

Somers Point, New Jersey, United States

Site Status RECRUITING

Akero Clinical Study Site

Sparta, New Jersey, United States

Site Status RECRUITING

Akero Clinical Study Site

Buffalo, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

Manhasset, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

New York, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

New York, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

New York, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

Rochester, New York, United States

Site Status RECRUITING

Akero Clinical Study Site

Chapel Hill, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Charlotte, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Charlotte, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Durham, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Fayetteville, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Morehead City, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Raleigh, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Statesville, North Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Akron, Ohio, United States

Site Status RECRUITING

Akero Clinical Study Site

Springboro, Ohio, United States

Site Status RECRUITING

Akero Clinical Study Site

Westlake, Ohio, United States

Site Status RECRUITING

Akero Clinical Study Site

Hershey, Pennsylvania, United States

Site Status RECRUITING

Akero Clinical Study Site

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Akero Clinical Study Site

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Akero Clinical Study Site

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

Akero Clinical Study Site

Charleston, South Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Columbia, South Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Summerville, South Carolina, United States

Site Status RECRUITING

Akero Clinical Study Site

Clarksville, Tennessee, United States

Site Status RECRUITING

Akero Clinical Study Site

Hermitage, Tennessee, United States

Site Status RECRUITING

Akero Clinical Study Site

Nashville, Tennessee, United States

Site Status RECRUITING

Akero Clinical Study Site

Amarillo, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Austin, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Austin, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Austin, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Bellaire, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Brownsville, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Corpus Christi, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Dallas, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Dallas, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Dallas, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Dallas, Texas, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Dallas, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Denison, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Edinburg, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Edinburg, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Fort Sam Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Fort Worth, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Garland, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Houston, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Pasadena, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Pharr, Texas, United States

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

San Antonio, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

San Antonio, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

San Antonio, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

San Antonio, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Sugar Land, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Sugar Land, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Waco, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Waco, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Webster, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Wichita Falls, Texas, United States

Site Status RECRUITING

Akero Clinical Study Site

Norfolk, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Richmond, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Richmond, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Richmond, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Richmond, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Roanoke, Virginia, United States

Site Status RECRUITING

Akero Clinical Study Site

Seattle, Washington, United States

Site Status RECRUITING

Akero Clinical Study Site

Madison, Wisconsin, United States

Site Status RECRUITING

Akero Clinical Study Site

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Site Status RECRUITING

Akero Clinical Study Site

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Site Status RECRUITING

Akero Clinical Study Site

La Plata, Buenos Aires, Argentina

Site Status RECRUITING

Akero Clinical Study Site

Ramos Mejía, Buenos Aires, Argentina

Site Status RECRUITING

Akero Clinical Study Site

Buenos Aires, Distrito Federal, Argentina

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Rosario, Sante Fe, Argentina

Site Status RECRUITING

Akero Clinical Study Site

Buenos Aires, , Argentina

Site Status RECRUITING

Akero Clinical Study Site

Broadmeadow, New South Wales, Australia

Site Status RECRUITING

Akero Clinical Study Site

Liverpool, New South Wales, Australia

Site Status RECRUITING

Akero Clinical Study Site

Westmead, New South Wales, Australia

Site Status RECRUITING

Akero Clinical Study Site

Herston, Queensland, Australia

Site Status RECRUITING

Akero Clinical Study Site

Adelaide, South Australia, Australia

Site Status RECRUITING

Akero Clinical Study Site

Box Hill, Victoria, Australia

Site Status RECRUITING

Akero Clinical Study Site

Clayton, Victoria, Australia

Site Status RECRUITING

Akero Clinical Study Site

Epping, Victoria, Australia

Site Status RECRUITING

Akero Clinical Study Site

Heidelberg, Victoria, Australia

Site Status RECRUITING

Akero Clinical Study Site

Melbourne, Victoria, Australia

Site Status RECRUITING

Akero Clinical Study Site

Murdoch, Western Australia, Australia

Site Status RECRUITING

Akero Clinical Study Site

Nedlands, Western Australia, Australia

Site Status RECRUITING

Akero Clinical Study Site

Perth, Western Australia, Australia

Site Status RECRUITING

Akero Clinical Study Site

Brasília, Federal District, Brazil

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Goiânia, Goiás, Brazil

Site Status RECRUITING

Akero Clinical Study Site

Belo Horizonte, Minas Gerais, Brazil

Site Status RECRUITING

Akero Clinical Study Site

Porto Alegre, Rio Grande do Sul, Brazil

Site Status RECRUITING

Akero Clinical Study Site

Edmonton, Alberta, Canada

Site Status RECRUITING

Akero Clinical Study Site

Toronto, Ontario, Canada

Site Status RECRUITING

Akero Clinical Study Site

Vaughan, Ontario, Canada

Site Status RECRUITING

Akero Clinical Study Site

Montreal, Quebec, Canada

Site Status RECRUITING

Akero Clinical Study Site

Terrebonne, Quebec, Canada

Site Status RECRUITING

Akero Clinical Study Site

La Serena, Coquimbo Region, Chile

Site Status RECRUITING

Akero Clinical Study Site

Las Condes, Santiago Metropolitan, Chile

Site Status RECRUITING

Akero Clinical Study Site

Santiago, Santiago Metropolitan, Chile

Site Status RECRUITING

Akero Clinical Study Site

Santiago, Santiago Metropolitan, Chile

Site Status RECRUITING

Akero Clinical Study Site

Santiago, Santiago Metropolitan, Chile

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Strasbourg, Bas-Rhin, France

Site Status RECRUITING

Akero Clinical Study Site

Limoges, Haute-Vienne, France

Site Status RECRUITING

Akero Clinical Study Site

Lille, Hauts-de-France, France

Site Status RECRUITING

Akero Clinical Study Site

Clichy, Hauts-de-Seine, France

Site Status RECRUITING

Akero Clinical Study Site

Vandœuvre-lès-Nancy, Lorraine, France

Site Status RECRUITING

Akero Clinical Study Site

Angers, Maine-et-Loire, France

Site Status RECRUITING

Akero Clinical Study Site

Toulouse, Occitanie, France

Site Status RECRUITING

Akero Clinical Study Site

Marseille, Provence-Alpes-Côte d'Azur Region, France

Site Status RECRUITING

Akero Clinical Study Site

Montpellier Cedex 5, Provence-Alpes-Côte d'Azur Region, France

Site Status RECRUITING

Akero Clinical Study Site

Nice, Provence-Alpes-Côte d'Azur Region, France

Site Status RECRUITING

Akero Clinical Study Site

Lyon, Rhône, France

Site Status RECRUITING

Akero Clinical Study Site

Créteil, Val-de-Marne, France

Site Status RECRUITING

Akero Clinical Study Site

Le Chesnay, Île-de-France Region, France

Site Status RECRUITING

Akero Clinical Study Site

Paris, Île-de-France Region, France

Site Status RECRUITING

Akero Clinical Study Site

Frankfurt am Main, Hesse, Germany

Site Status RECRUITING

Akero Clinical Study Site

Homburg, Saarland, Germany

Site Status RECRUITING

Akero Clinical Study Site

Leipzig, Saxony, Germany

Site Status RECRUITING

Akero Clinical Study Site

Leipzig, Saxony, Germany

Site Status RECRUITING

Akero Clinical Study Site

Lübeck, Schleswig-Holstein, Germany

Site Status RECRUITING

Akero Clinical Study Site

Berlin, , Germany

Site Status RECRUITING

Akero Clinical Study Site

Hyderabad, Andhra Pradesh, India

Site Status RECRUITING

Akero Clinical Study Site

Surat, Gujarat, India

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

Surat, Gujarat, India

Site Status RECRUITING

Akero Clinical Study Site

Vadodara, Gujarat, India

Site Status RECRUITING

Akero Clinical Study Site

Mysore, Karnataka, India

Site Status RECRUITING

Akero Clinical Study Site

Thiruvananthapuram, Kerala, India

Site Status RECRUITING

Akero Clinical Study Site

Mumbai, Maharashtra, India

Site Status RECRUITING

Akero Clinical Study Site

Mumbai, Maharashtra, India

Site Status RECRUITING

Akero Clinical Study Site

Nagpur, Maharashtra, India

Site Status RECRUITING

Akero Clinical Study Site

Pune, Maharashtra, India

Site Status ACTIVE_NOT_RECRUITING

Akero Clinical Study Site

New Delhi, National Capital Territory of Delhi, India

Site Status RECRUITING

Akero Clinical Study Site

New Delhi, National Capital Territory of Delhi, India

Site Status RECRUITING

Akero Clinical Study Site

New Delhi, National Capital Territory of Delhi, India

Site Status RECRUITING

Akero Clinical Study Site

Chandigarh, Punjab, India

Site Status RECRUITING

Akero Clinical Study Site

Ludhiana, Punjab, India

Site Status RECRUITING

Akero Clinical Study Site

Jaipur, Rajasthan, India

Site Status RECRUITING

Akero Clinical Study Site

Jaipur, Rajasthan, India

Site Status RECRUITING

Akero Clinical Study Site

Coimbatore, Tamil Nadu, India

Site Status RECRUITING

Akero Clinical Study Site

Hyderabad, Telangana, India

Site Status RECRUITING

Akero Clinical Study Site

Varanasi, Uttar Pradesh, India

Site Status RECRUITING

Akero Clinical Study Site

Varanasi, Uttar Pradesh, India

Site Status RECRUITING

Akero Clinical Study Site

Rishikesh, Uttarakhand, India

Site Status RECRUITING

Akero Clinical Study Site

Kolkata, West Bengal, India

Site Status RECRUITING

Akero Clinical Study Site

Kolkata, West Bengal, India

Site Status RECRUITING

Akero Clinical Study Site

Kolkata, West Bengal, India

Site Status RECRUITING

Akero Clinical Study Site

Petah Tikva, Central District, Israel

Site Status RECRUITING

Akero Clinical Study Site

Ramat Gan, Central District, Israel

Site Status RECRUITING

Akero Clinical Study Site

Haifa, Haifa District, Israel

Site Status RECRUITING

Akero Clinical Study Site

Afula, Northern District, Israel

Site Status RECRUITING

Akero Clinical Study Site

Nahariya, Northern District, Israel

Site Status RECRUITING

Akero Clinical Study Site

Haifa, , Israel

Site Status RECRUITING

Akero Clinical Study Site

Jerusalem, , Israel

Site Status RECRUITING

Akero Clinical Study Site

Jerusalem, , Israel

Site Status RECRUITING

Akero Clinical Study Site

Tel Aviv, , Israel

Site Status RECRUITING

Akero Clinical Study Site

Tel Aviv, , Israel

Site Status RECRUITING

Akero Clinical Study Site

Foggia, Apulia, Italy

Site Status RECRUITING

Akero Clinical Study Site

San Giovanni Rotondo, Foggia, Italy

Site Status RECRUITING

Akero Clinical Study Site

Rozzano, Milan, Italy

Site Status RECRUITING

Akero Clinical Study Site

Torino, Turin, Italy

Site Status RECRUITING

Akero Clinical Study Site

Bologna, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Messina, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Milan, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Milan, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Modena, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Novara, , Italy

Site Status RECRUITING

Akero Clinical Study Site

Guadalajara, Jalisco, Mexico

Site Status RECRUITING

Akero Clinical Study Site

Cuauhtémoc, Mexico City, Mexico

Site Status RECRUITING

Akero Clinical Study Site

Mexico City, Mexico City, Mexico

Site Status RECRUITING

Akero Clinical Study Site

Mérida, Yucatán, Mexico

Site Status RECRUITING

Akero Clinical Study Site

Benito Juárez, , Mexico

Site Status RECRUITING

Akero Clinical Study Site

Poznan, Greater Poland Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Krakow, Lesser Poland Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Lodz, Lódzkie, Poland

Site Status RECRUITING

Akero Clinical Study Site

Warsaw, Masovian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Warsaw, Masovian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Częstochowa, Silesian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Katowice, Silesian Voivodeship, Poland

Site Status RECRUITING

Akero Clinical Study Site

Manatí, , Puerto Rico

Site Status RECRUITING

Akero Clinical Study Site

Mayagüez, , Puerto Rico

Site Status RECRUITING

Akero Clinical Study Site

San Juan, , Puerto Rico

Site Status RECRUITING

Akero Clinical Study Site

Daegu, Daegu Gwang'yeogsi [Taegu-Kwangyokshi], South Korea

Site Status RECRUITING

Akero Clinical Study Site

Incheon, Gyeonggi-do, South Korea

Site Status RECRUITING

Akero Clinical Study Site

Goyang-si, Gyeonggido, South Korea

Site Status RECRUITING

Akero Clinical Study Site

Daegu, Gyeongsangbugdo [Kyongsangbuk-do], South Korea

Site Status RECRUITING

Akero Clinical Study Site

Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], South Korea

Site Status RECRUITING

Akero Clinical Study Site

Seoul, Seoul Teugbyeolsi, South Korea

Site Status RECRUITING

Akero Clinical Study Site

Sabadell, Barcelona, Spain

Site Status RECRUITING

Akero Clinical Study Site

Santander, Cantabria, Spain

Site Status RECRUITING

Akero Clinical Study Site

Majadahonda, Madrid, Spain

Site Status RECRUITING

Akero Clinical Study Site

Barcelona, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Madrid, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Madrid, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Seville, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Valencia, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Valencia, , Spain

Site Status RECRUITING

Akero Clinical Study Site

Lugano, Canton Ticino, Switzerland

Site Status RECRUITING

Akero Clinical Study Site

Bern, , Switzerland

Site Status RECRUITING

Akero Clinical Study Site

Sankt Gallen, , Switzerland

Site Status RECRUITING

Akero Clinical Study Site

Zurich, , Switzerland

Site Status RECRUITING

Akero Clinical Study Site

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Akero Clinical Study Site

Bursa, , Turkey (Türkiye)

Site Status RECRUITING

Akero Clinical Study Site

Rize, , Turkey (Türkiye)

Site Status RECRUITING

Akero Clinical Study Site

London, England, United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

Nottingham, England, United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

Birmingham, , United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

London, , United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

London, , United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

Newcastle upon Tyne, , United Kingdom

Site Status RECRUITING

Akero Clinical Study Site

Whitechapel, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Brazil Canada Chile France Germany India Israel Italy Mexico Poland Puerto Rico South Korea Spain Switzerland Turkey (Türkiye) United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Akero Study Director

Role: CONTACT

[email protected]
650-487-6488

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Akero Site 0129

Role: primary

Akero Site 0233

Role: primary

Akero Site 9106

Role: primary

Akero Site 9104

Role: primary

Akero Site 0278

Role: primary

Akero Site 9210

Role: primary

Akero Site 9144

Role: primary

Akero Site 0234

Role: primary

Akero Site 0209

Role: primary

Akero Site 0150

Role: primary

Akero Site 0106

Role: primary

Akero Site 9214

Role: primary

Akero Site 0132

Role: primary

Akero Site 0266

Role: primary

Akero Site 0263

Role: primary

Akero Site 0285

Role: primary

Akero Site 0188

Role: primary

Akero Site 0236

Role: primary

Akero Site 0206

Role: primary

Akero Site 0261

Role: primary

Akero Site 9250

Role: primary

Akero Site 0191

Role: primary

Akero Site 0147

Role: primary

Akero Site 0280

Role: primary

Akero Site 0217

Role: primary

Akero Site 0260

Role: primary

Akero Site 9243

Role: primary

Akero Site 0213

Role: primary

Akero Site 0262

Role: primary

Akero Site 0153

Role: primary

Akero Site 0222

Role: primary

Akero Site 0251

Role: primary

Akero Site 0267

Role: primary

Akero Site 9134

Role: primary

Akero Site 9242

Role: primary

Akero Site 9135

Role: primary

Akero Site 9203

Role: primary

Akero Site 9248

Role: primary

Akero Site 0271

Role: primary

Akero Site 0248

Role: primary

Akero Site 0137

Role: primary

Akero Site 0252

Role: primary

Akero Site 0243

Role: primary

Akero Site 0138

Role: primary

Akero Site 0257

Role: primary

Akero Site 9127

Role: primary

Akero Site 0250

Role: primary

Akero Site 0239

Role: primary

Akero Site 0295

Role: primary

Akero Site 9218

Role: primary

Akero Site 0242

Role: primary

Akero Site 0270

Role: primary

Akero Site 0235

Role: primary

Akero Site 0230

Role: primary

Akero Site 0183

Role: primary

Akero Site 9111

Role: primary

Akero Site 9245

Role: primary

Akero Site 0254

Role: primary

Akero Site 0290

Role: primary

Akero Site 9235

Role: primary

Akero Site 0146

Role: primary

Akero Site 9136

Role: primary

Akero Site 0203

Role: primary

Akero Site 9220

Role: primary

Akero Site 0195

Role: primary

Akero Site 0112

Role: primary

Akero Site 0282

Role: primary

Akero Site 9102

Role: primary

Akero Site 0109

Role: primary

Akero Site 9145

Role: primary

Akero Site 0283

Role: primary

Akero Site 0108

Role: primary

Akero Site 0227

Role: primary

Akero Site 0181

Role: primary

Akero Site 0204

Role: primary

Akero Site 0210

Role: primary

Akero Site 0240

Role: primary

Akero Site 0277

Role: primary

Akero Site 0141

Role: primary

Akero Site 9208

Role: primary

Akero Site 0276

Role: primary

Akero Site 0296

Role: primary

Akero Site 9142

Role: primary

Akero Site 0105

Role: primary

Akero Site 0116

Role: primary

Akero Site 0117

Role: primary

Akero Site 0241

Role: primary

Akero Site 0208

Role: primary

Akero Site 0198

Role: primary

Akero Site 0148

Role: primary

Akero Site 0160

Role: primary

Akero Site 0228

Role: primary

Akero Site 0192

Role: primary

Akero Site 9147

Role: primary

Akero Site 0225

Role: primary

Akero Site 0224

Role: primary

Akero Site 9227

Role: primary

Akero Site 9128

Role: primary

Akero Site 0169

Role: primary

Akero Site 0142

Role: primary

Akero Site 0284

Role: primary

Akero Site 9233

Role: primary

Akero Site 9226

Role: primary

Akero Site 0264

Role: primary

Akero Site 0207

Role: primary

Akero Site 9132

Role: primary

Akero Site 0102

Role: primary

Akero Site 0246

Role: primary

Akero Site 0151

Role: primary

Akero Site 9238

Role: primary

Akero Site 0144

Role: primary

Akero Site 9123

Role: primary

Akero Site 9130

Role: primary

Akero Site 0104

Role: primary

Akero Site 0131

Role: primary

Akero Site 9114

Role: primary

Akero Site 0281

Role: primary

Akero Site 0165

Role: primary

Akero Site 0154

Role: primary

Akero Site 0223

Role: primary

Akero Site 0126

Role: primary

Akero Site 0253

Role: primary

Akero Site 0221

Role: primary

Akero Site 0164

Role: primary

Akero Site 0244

Role: primary

Akero Site 9117

Role: primary

Akero Site 9205

Role: primary

Akero Site 0229

Role: primary

Akero Site 9211

Role: primary

Akero Site 9140

Role: primary

Akero Site 9223

Role: primary

Akero Site 0293

Role: primary

Akero Site 0258

Role: primary

Akero Site 0249

Role: primary

Akero Site 9252

Role: primary

Akero Site 0292

Role: primary

Akero Site 0185

Role: primary

Akero Site 9202

Role: primary

Akero Site 0125

Role: primary

Akero Site 0289

Role: primary

Akero Site 0216

Role: primary

Akero Site 0299

Role: primary

Akero Site 9246

Role: primary

Akero Site 0279

Role: primary

Akero Site 9204

Role: primary

Akero Site 9247

Role: primary

Akero Site 0143

Role: primary

Akero Site 0212

Role: primary

Akero Site 0103

Role: primary

Akero Site 9120

Role: primary

Akero Site 9115

Role: primary

Akero Site 0139

Role: primary

Akero Site 0119

Role: primary

Akero Site 0259

Role: primary

Akero Site 0305

Role: primary

Akero Site 0307

Role: primary

Akero Site 0304

Role: primary

Akero Site 0303

Role: primary

Akero Site 0308

Role: primary

Akero Site 0302

Role: primary

Akero Site 0408

Role: primary

Akero Site 0413

Role: primary

Akero Site 0401

Role: primary

Akero Site 0414

Role: primary

Akero Site 0407

Role: primary

Akero Site 0412

Role: primary

Akero Site 0402

Role: primary

Akero Site 0410

Role: primary

Akero Site 0405

Role: primary

Akero Site 0403

Role: primary

Akero Site 0411

Role: primary

Akero Site 0415

Role: primary

Akero Site 0406

Role: primary

Akero Site 2003

Role: primary

Akero Site 2002

Role: primary

Akero Site 2001

Role: primary

Akero Site 0501

Role: primary

Akero Site 0502

Role: primary

Akero Site 0504

Role: primary

Akero Site 0506

Role: primary

Akero Site 0505

Role: primary

Akero Site 2104

Role: primary

Akero Site 2101

Role: primary

Akero Site 2105

Role: primary

Akero Site 2102

Role: primary

Akero Site 0607

Role: primary

Akero Site 0609

Role: primary

Akero Site 0613

Role: primary

Akero Site 0603

Role: primary

Akero Site 0611

Role: primary

Akero Site 0602

Role: primary

Akero Site 0610

Role: primary

Akero Site 0601

Role: primary

Akero Site 0608

Role: primary

Akero Site 0606

Role: primary

Akero Site 0604

Role: primary

Akero Site 0614

Role: primary

Akero Site 0612

Role: primary

Akero Site 0605

Role: primary

Akero Site 0702

Role: primary

Akero Site 0716

Role: primary

Akero Site 0703

Role: primary

Akero Site 0708

Role: primary

Akero Site 0713

Role: primary

Akero Site 0701

Role: primary

Akero Site 1929

Role: primary

Akero Site 1911

Role: primary

Akero Site 1906

Role: primary

Akero Site 1930

Role: primary

Akero Site 1922

Role: primary

Akero Site 1931

Role: primary

Akero Site 1926

Role: primary

Akero Site 1909

Role: primary

Akero Site 1924

Role: primary

Akero Site 1904

Role: primary

Akero Site 1916

Role: primary

Akero Site 1908

Role: primary

Akero Site 1928

Role: primary

Akero Site 1903

Role: primary

Akero Site 1902

Role: primary

Akero Site 1920

Role: primary

Akero Site 1912

Role: primary

Akero Site 1919

Role: primary

Akero Site 1921

Role: primary

Akero Site 1923

Role: primary

Akero Site 1914

Role: primary

Akero Site 1907

Role: primary

Akero Site 1917

Role: primary

Akero Site 0803

Role: primary

Akero Site 0802

Role: primary

Akero Site 0806

Role: primary

Akero Site 0810

Role: primary

Akero Site 0807

Role: primary

Akero Site 0804

Role: primary

Akero Site 0809

Role: primary

Akero Site 0808

Role: primary

Akero Site 0801

Role: primary

Akero Site 0811

Role: primary

Akero Site 0909

Role: primary

Akero Site 0901

Role: primary

Akero Site 0904

Role: primary

Akero Site 0910

Role: primary

Akero Site 0908

Role: primary

Akero Site 0912

Role: primary

Akero Site 0911

Role: primary

Akero Site 0902

Role: primary

Akero Site 0906

Role: primary

Akero Site 0905

Role: primary

Akero Site 1103

Role: primary

Akero Site 8237

Role: primary

Akero Site 1106

Role: primary

Akero Site 1108

Role: primary

Akero Site 1105

Role: primary

Akero Site 1205

Role: primary

Akero Site 1212

Role: primary

Akero Site 1204

Role: primary

Akero Site 1213

Role: primary

Akero Site 1214

Role: primary

Akero Site 1211

Role: primary

Akero Site 1203

Role: primary

Akero Site 1206

Role: primary

Akero Site 1208

Role: primary

Akero Site 0177

Role: primary

Akero Site 0272

Role: primary

Akero Site 9215

Role: primary

Akero Site 1306

Role: primary

Akero Site 1308

Role: primary

Akero Site 1303

Role: primary

Akero Site 1304

Role: primary

Akero Site 1301

Role: primary

Akero Site 1305

Role: primary

Akero Site 1409

Role: primary

Akero Site 1406

Role: primary

Akero Site 1404

Role: primary

Akero Site 1405

Role: primary

Akero Site 1401

Role: primary

Akero Site 1408

Role: primary

Akero Site 1402

Role: primary

Akero Site 1410

Role: primary

Akero Site 1403

Role: primary

Akero Site 1505

Role: primary

Akero Site 1502

Role: primary

Akero Site 1501

Role: primary

Akero Site 1506

Role: primary

Akero Site 1705

Role: primary

Akero Site 1704

Role: primary

Akero Site 1706

Role: primary

Akero Site 1806

Role: primary

Akero Site 1817

Role: primary

Akero Site 1804

Role: primary

Akero Site 1802

Role: primary

Akero Site 1813

Role: primary

Akero Site 1805

Role: primary

Akero Site 1809

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AK-US-001-0106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
NCT06920043 RECRUITING PHASE2
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374 RECRUITING PHASE3
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
NCT06465186 ACTIVE_NOT_RECRUITING PHASE2
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT02704403 TERMINATED PHASE3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169 RECRUITING PHASE3
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
NCT04321031 COMPLETED PHASE2
A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)
NCT04583423 TERMINATED PHASE2
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07288138 RECRUITING PHASE2
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
NCT07221227 RECRUITING PHASE3
Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)
NCT03912532 COMPLETED PHASE2
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT02927314 COMPLETED PHASE2
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344 ACTIVE_NOT_RECRUITING PHASE2
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
NCT02854605 COMPLETED PHASE2
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
NCT00590161 COMPLETED PHASE2
Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT04321343 COMPLETED PHASE2
A Study in Participants With Non-cirrhotic NASH With Fibrosis
NCT05638737 COMPLETED PHASE2
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
NCT05118360 WITHDRAWN PHASE2
6-week Safety and PD Study in Adults With NAFLD
NCT03256526 COMPLETED PHASE2
A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
NCT06675929 ACTIVE_NOT_RECRUITING PHASE2
Phase 2a Study of HPG1860 in Subjects With NASH
NCT05338034 UNKNOWN PHASE2
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
NCT05500222 ACTIVE_NOT_RECRUITING PHASE3
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
NCT03486912 COMPLETED PHASE2
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728 RECRUITING PHASE3
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
NCT06750276 COMPLETED PHASE2
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
NCT05877547 COMPLETED PHASE2